Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 2004 May;80(943):271–276. doi: 10.1136/pgmj.2003.010843

Use of diuretics in cardiovascular disease: (2) hypertension

S Shah 1, S Anjum 1, W Littler 1
PMCID: PMC1742995  PMID: 15138316

Abstract

Hypertension is a common condition associated with increased mortality and multiple morbidities. Evidence based management of hypertension is known to improve both the short term and the long term outcomes in patients with this condition. There are several general measures and pharmacological agents that are known to treat hypertension adequately. Diuretics, in particular low dose thiazide and thiazide-like diuretics, are widely used in the treatment of hypertension. They have excellent outcome data and high safety and low side effects profiles. In this article, the physiology, pharmacological actions, side effects, and outcome data of the use of diuretics in hypertension are reviewed. In addition, the effective use of diuretics in the management of hypertension is discussed.

Full Text

The Full Text of this article is available as a PDF (194.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ambrosioni E., Safar M., Degaute J. P., Malin P. L., MacMahon M., Pujol D. R., de Cordoüe A., Guez D. Low-dose antihypertensive therapy with 1.5 mg sustained-release indapamide: results of randomised double-blind controlled studies. European study group. J Hypertens. 1998 Nov;16(11):1677–1684. doi: 10.1097/00004872-199816110-00015. [DOI] [PubMed] [Google Scholar]
  2. Birnbaum Y., Sclarovsky S., Ben-Ami R., Rechavia E., Strasberg B., Kusniec J., Mager A., Sulkes J. Polymorphous ventricular tachycardia early after acute myocardial infarction. Am J Cardiol. 1993 Mar 15;71(8):745–749. doi: 10.1016/0002-9149(93)91021-9. [DOI] [PubMed] [Google Scholar]
  3. Brater D. C. Diuretic therapy. N Engl J Med. 1998 Aug 6;339(6):387–395. doi: 10.1056/NEJM199808063390607. [DOI] [PubMed] [Google Scholar]
  4. Brater D. C. Pharmacology of diuretics. Am J Med Sci. 2000 Jan;319(1):38–50. doi: 10.1097/00000441-200001000-00004. [DOI] [PubMed] [Google Scholar]
  5. Burris J. F., Weir M. R., Oparil S., Weber M., Cady W. J., Stewart W. H. An assessment of diltiazem and hydrochlorothiazide in hypertension. Application of factorial trial design to a multicenter clinical trial of combination therapy. JAMA. 1990 Mar 16;263(11):1507–1512. [PubMed] [Google Scholar]
  6. Collins R., Peto R., MacMahon S., Hebert P., Fiebach N. H., Eberlein K. A., Godwin J., Qizilbash N., Taylor J. O., Hennekens C. H. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet. 1990 Apr 7;335(8693):827–838. doi: 10.1016/0140-6736(90)90944-z. [DOI] [PubMed] [Google Scholar]
  7. Dahlöf B., Lindholm L. H., Hansson L., Scherstén B., Ekbom T., Wester P. O. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension) Lancet. 1991 Nov 23;338(8778):1281–1285. doi: 10.1016/0140-6736(91)92589-t. [DOI] [PubMed] [Google Scholar]
  8. Dzau V. J. Evolution of the clinical management of hypertension. Emerging role of "specific" vasodilators as initial therapy. Am J Med. 1987 Jan 5;82(1A):36–43. doi: 10.1016/0002-9343(87)90142-2. [DOI] [PubMed] [Google Scholar]
  9. Frishman W. H., Bryzinski B. S., Coulson L. R., DeQuattro V. L., Vlachakis N. D., Mroczek W. J., Dukart G., Goldberg J. D., Alemayehu D., Koury K. A multifactorial trial design to assess combination therapy in hypertension. Treatment with bisoprolol and hydrochlorothiazide. Arch Intern Med. 1994 Jul 11;154(13):1461–1468. [PubMed] [Google Scholar]
  10. Greenberg S., McGowan C., Xie J., Summer W. R. Selective pulmonary and venous smooth muscle relaxation by furosemide: a comparison with morphine. J Pharmacol Exp Ther. 1994 Sep;270(3):1077–1085. [PubMed] [Google Scholar]
  11. Guo X. H., Yap Y. G., Chen L. J., Huang J., Camm A. J. Correlation of coronary angiography with "tombstoning" electrocardiographic pattern in patients after acute myocardial infarction. Clin Cardiol. 2000 May;23(5):347–352. doi: 10.1002/clc.4960230508. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hebert P. R., Moser M., Mayer J., Glynn R. J., Hennekens C. H. Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart disease. Arch Intern Med. 1993 Mar 8;153(5):578–581. [PubMed] [Google Scholar]
  13. Kaplan N. M. Diuretics as a basis of antihypertensive therapy. An overview. Drugs. 2000;59 (Suppl 2):21–40. doi: 10.2165/00003495-200059002-00003. [DOI] [PubMed] [Google Scholar]
  14. Kaplan N. M. Southwestern Internal Medicine Conference: difficult-to-treat hypertension. Am J Med Sci. 1995 Jun;309(6):339–346. doi: 10.1097/00000441-199506000-00008. [DOI] [PubMed] [Google Scholar]
  15. Materson B. J., Reda D. J., Cushman W. C. Department of veterans Affairs single-drug therapy of hypertension study. Revised figures and new data. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Am J Hypertens. 1995 Feb;8(2):189–192. doi: 10.1016/0895-7061(94)00196-i. [DOI] [PubMed] [Google Scholar]
  16. Pearce K. A., Furberg C. D., Psaty B. M., Kirk J. Cost-minimization and the number needed to treat in uncomplicated hypertension. Am J Hypertens. 1998 May;11(5):618–629. doi: 10.1016/s0895-7061(97)00488-3. [DOI] [PubMed] [Google Scholar]
  17. Pickkers P., Hughes A. D., Russel F. G., Thien T., Smits P. Thiazide-induced vasodilation in humans is mediated by potassium channel activation. Hypertension. 1998 Dec;32(6):1071–1076. doi: 10.1161/01.hyp.32.6.1071. [DOI] [PubMed] [Google Scholar]
  18. Psaty B. M., Smith N. L., Siscovick D. S., Koepsell T. D., Weiss N. S., Heckbert S. R., Lemaitre R. N., Wagner E. H., Furberg C. D. Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. JAMA. 1997 Mar 5;277(9):739–745. [PubMed] [Google Scholar]
  19. Puschett J. B. Diuretics and the therapy of hypertension. Am J Med Sci. 2000 Jan;319(1):1–9. doi: 10.1097/00000441-200001000-00001. [DOI] [PubMed] [Google Scholar]
  20. Ramsay L. E., Williams B., Johnston G. D., MacGregor G. A., Poston L., Potter J. F., Poulter N. R., Russell G. British Hypertension Society guidelines for hypertension management 1999: summary. BMJ. 1999 Sep 4;319(7210):630–635. doi: 10.1136/bmj.319.7210.630. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Reyes A. J., Taylor S. H. Diuretics in cardiovascular therapy: the new clinicopharmacological bases that matter. Cardiovasc Drugs Ther. 1999 Sep;13(5):371–398. doi: 10.1023/a:1007835821228. [DOI] [PubMed] [Google Scholar]
  22. Singer D. R., Markandu N. D., Sugden A. L., Miller M. A., MacGregor G. A. Sodium restriction in hypertensive patients treated with a converting enzyme inhibitor and a thiazide. Hypertension. 1991 Jun;17(6 Pt 1):798–803. doi: 10.1161/01.hyp.17.6.798. [DOI] [PubMed] [Google Scholar]
  23. Staessen J. A., Fagard R., Thijs L., Celis H., Arabidze G. G., Birkenhäger W. H., Bulpitt C. J., de Leeuw P. W., Dollery C. T., Fletcher A. E. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet. 1997 Sep 13;350(9080):757–764. doi: 10.1016/s0140-6736(97)05381-6. [DOI] [PubMed] [Google Scholar]
  24. Weir M. R., Flack J. M., Applegate W. B. Tolerability, safety, and quality of life and hypertensive therapy: the case for low-dose diuretics. Am J Med. 1996 Sep 30;101(3A):83S–92S. doi: 10.1016/s0002-9343(96)00271-9. [DOI] [PubMed] [Google Scholar]
  25. Wiemer G., Fink E., Linz W., Hropot M., Schölkens B. E., Wohlfart P. Furosemide enhances the release of endothelial kinins, nitric oxide and prostacyclin. J Pharmacol Exp Ther. 1994 Dec;271(3):1611–1615. [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES